U.S. flag
      An official website of the United States government, Department of Justice.
        Here's how you know
      Here's how you know**Official websites use .gov**
            
            A **.gov** website belongs to an official government organization in the United States.
      **Secure .gov websites use HTTPS**
            
            A **lock** (
            A locked padlock
            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Menu

      
        close

            
            
                                              About NIJ
        
                    
  
          About NIJ
      
    
          The NIJ Director
          How NIJ Is Organized
          Mission and Guiding Principles
          Research and Development Process
          Strategic Framework
          Assessments of NIJ
          Annual Reports & Reports to Congress
          Staff Directory
          Funding & Awards
        
                    
  
          Funding & Awards
      
    
          Current Funding
          Forthcoming Funding
          Expired Funding
          Awards: Listing of Funded Projects
          Guidance for Applicants and Awardees
          Fellowship & Student Programs
          Travel Scholarships
          NIJ Challenge Program
          Library & Multimedia
        
                    
  
          Library & Multimedia
      
    
          NIJ Journal
          Podcasts
          Publications Listing
          Multimedia Listing
          Rated Practices on CrimeSolutions
          Rated Programs on CrimeSolutions
          Software & Databases
          Datasets
          Patents
          Topics
        
                    
  
          Topics
      
    
          Article Listing
          Corrections
          Courts
          Crime Prevention
          Crimes
          Drugs and Crime
          Equipment and Technology
          Forensic Sciences
          Youth Justice
          Justice System Reform
          Law Enforcement
          Tribal Crime and Justice
          Victims of Crime
          Events
        
                    
  
          Events
      
    
          NIJ 2024 Research Conference
          Scheduled Events
          On-Demand Events
          Research Meetings & Workshops
          NIJ-Hosted Online Training

                            
                                About
          Contact Us
          Subscribe
          Topics A-Z
                  Share
FacebookXLinkedInRedditPinterestEmail Home
                            Library & Multimedia
 Prediction of Drug Interactions With Methadone, Buprenorphine and Oxycodone From In Vitro Inhibition of Metabolism
NCJ Number
              250127

Author(s)
          David E. Moody
Date Published

July 2016
Length
              51 pages
Annotation
              This is a progress report on a project that is testing the hypothesis that inhibition of in vitro drug metabolism can predict potential drug interactions with the opioids buprenorphine, methadone, and oxycodone.
Abstract
              The overall assessment is that substantial progress has been made in meeting project objectives. Researchers have optimized incubation conditions for buprenorphine, methadone, and oxycodone in human liver microsomes (HLM) and with the relevant DNA-expressed cytochrome P450s (rCYPs) (i.e., CYP3A4 for all three substrates, 2C8 for buprenorphine, 2B6 for methadone, and 2D6 and 2C18 for oxycodone). Researchers also established the following positive controls for the system: troleandomycin (TAO) with CYP3A4 metabolism of buprenorphine, oxycodone and methadone, and gemfibrozil glucuronide for CYP2C8 metabolism of buprenorphine. Progress was made in another area in screening the inhibitory potential of three drug classes in HLM using the project's +/- 15-minute pre-incubation of inhibitor with HLM and source of NADPH protocol that indicates both in vitro inhibition and TDI. This has been done for four H2-receptor antagonists, and five proton pump inhibitors (PPIs) with methadone and oxycodone at 2.0 ìM substrate concentration, and for twelve antifungal azole compounds at 20 ìM substrate for all three opioids. In addition, for the relevant compounds (most), researchers have determined IC50 values for the inhibition of relevant CYP450s, and have performed in vivo extrapolations to estimate in vivo inhibitory potential. Further, for the relevant compounds (most), the project determined IC50 values for the inhibition of relevant CYP450s, and have performed in vivo extrapolations to estimate in vivo inhibitory potential. Following further mechanistic studies, the project will submit manuscripts on TDI by cimetidine and PPIs. Although much remains to be done in the project's studies on in vitro inhibition of opioid metabolism, significant in-roads have been achieved. 22 figures, 9 tables, and 71 references
      
  
          Additional Details
Grant Number(s)
        2011-DN-BX-K532


  
  
        
  Agencies
        NIJ-Sponsored


  
  
        
  Publication Type
        Research (Applied/Empirical)
                                Report (Study/Research)
                                Report (Grant Sponsored)


  
  
        
  Award
        Prediction of drug interactions with methadone, buprenorphine and oxycodone from in vitro inhibition of metabolism
    
  
  
Date Published: July 1, 2016
    
          Downloads
        
                      PDF

Side navigation
  

        

  
  
              NIJ Journal
    
      
            
            
            
      Podcasts
    
      
            
            
            
      Publications Listing
    
      
            
            
            
      Multimedia Listing
    
      
            
            
            
      Rated Practices on CrimeSolutions
    
      
            
            
            
      Rated Programs on CrimeSolutions
    
      
            
            
            
      Software & Databases
    
      
            
            
            
      Datasets
    
      
            
            
            
      PatentsRelated Topics
        
                Drug analysis
        Drug effects
        Drugs
        Forensic sciences
        Justice system



  
Similar Publications
        
                      What’s Known and Unknown About Marijuana (Part Two)
                  Reversible and irreversible protein glutathionylation: biological and clinical aspects
                  Understanding Work-Related Stress among Medicolegal Death Investigators: A National Survey and Mixed-Methods Impact Study
 Top

      National Institute of Justice

        
        
                        About NIJ
                    About NIJ
      
    
                  How NIJ Is Organized
      
    
                  NIJ Director
      
    
                  Research Disclaimer
      
    
                  Funding & Awards
                    Funding & Awards Home
      
    
                  Awards Listing
      
    
                  Current Funding
      
    
                  Guidance for Applicants and Awardees
      
    
                  Resources
                    Events
      
    
                  Podcasts
      
    
                  Publications
      
    
                  Topics
      
    
                  Multimedia
      
    
                  Reuse Policy
      
    
                  Contacts
                    Contact NIJ
      
    
                  Staff Directory
      
    
                  Submit a FOIA Request
      
    
                  File a Civil Rights ComplaintFacebook
          
                      X
          
                      YouTube
  

      810 7th St. NW, Washington, D.C. 20531
      
              Secondary Footer link menu
            Accessibility
              Plain Language
              Privacy Policy
              Legal Policies and Disclaimer
              No FEAR Act
              Freedom of Information Act
              USA.gov
              Justice.gov